Sigachi Industries profit and loss

Latest FY26

Revenue: ₹478cr−2.1% on FY25
EBITDA: ₹53.7cr−46.2% on FY25
Net profit: −₹82.8cr₹70.5 cr in FY25
EPS: −₹2.14₹2.06 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	471	478	488	399	302	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	5.3	8.3	20.5	11.7	6.7
	476	486	509	411	309
	193	200	235	160	141
	32.7	29.5	3.1	40.0	1.4
	17.1	18.5	−16.3	−5.1	−4.0
	103	110	73.6	57.2	38.3
	13.6	13.9	12.4	7.8	4.3
	17.3	17.6	15.8	10.8	6.6
	79.4	66.0	92.5	70.0	66.7
	456	456	416	341	254
	46.2	53.7	100.0	76.7	58.7
	28.9	36.2	84.2	65.9	52.1
Profit
	20.6	30.5	92.3	69.8	54.5
	2.8	−118	0.0	0.0	0.0
	23.4	−87.7	92.3	69.8	54.5
	4.9	2.4	14.5	12.1	11.1
	−7.8	−7.3	7.3	0.4	−0.2
	−2.9	−4.9	21.9	12.5	10.9
	26.3	−82.8	70.5	57.3	43.5
	26.3	−82.8	70.5	57.3	43.5
	5.1	3.2	−0.1	0.0	0.1
	31.4	−79.6	70.3	57.3	43.7
	25.4	−81.8	69.6	57.2	43.5
	1.0	−1.0	0.9	0.1	0.0
Per share
	₹0.67	−₹2.14	₹2.06	₹1.81	₹14.16
	₹0.67	−₹2.14	₹2.06	₹1.54	₹14.16
Other comprehensive income — detail
	5.1	3.2	−0.1	—	—
	−0.1	−0.1	−0.7	0.0	−0.1
	−0.0	−0.0	−0.1	—	—
	—	—	—	0.0	−0.0
	5.1	3.2	0.5	0.0	0.2
	30.4	−78.6	69.5	57.2	43.7
	1.0	−1.0	0.8	0.1	0.0
Per share — as-filed variants
	₹0.67	−₹2.14	₹2.06	₹1.81	₹14.16
	₹0.67	−₹2.14	₹2.06	₹1.54	₹14.16
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	228	230	266	204	164
	48.5%	48.2%	54.5%	51.1%	54.2%
Adjusted (ex-exceptional items) — derived
	20.6	30.5	92.3	69.8	54.5
	2.8	−118	0.0	0.0	0.0
	23.5	28.8	70.5	57.3	43.5
	₹0.60	₹0.74	₹2.06	₹1.81	₹14.16

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SIGACHI₹26.54

Sigachi Industries Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersLINCOLN THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY NGLFINEMcap ₹1,014 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	302.0	399.0	488.2	477.8	470.9
Other Income	6.7	11.7	20.5	8.3	5.3
Total Income	308.7	410.6	508.8	486.1	476.2
Expenses
+ Cost of Materials Consumed	141.0	160.3	235.3	199.7	192.8
+ Purchases of Stock-in-Trade	1.4	40.0	3.1	29.5	32.7
+ Changes in Inventories	-4.0	-5.1	-16.3	18.5	17.1
+ Employee Benefit Expense	38.3	57.2	73.6	110.4	102.8
+ Finance Costs	4.3	7.8	12.4	13.9	13.6
+ Depreciation & Amortisation	6.6	10.8	15.8	17.6	17.3
+ Other Expenses	66.7	70.0	92.5	66.0	79.4
Total Expenses	254.2	340.9	416.4	455.6	455.6
EBITDA	58.7	76.7	100.0	53.7	46.2
EBIT	52.1	65.9	84.2	36.2	28.9
Profit
PBT before Exceptional Items	54.5	69.8	92.3	30.5	20.6
+ Exceptional Items	0.0	0.0	0.0	-118.2	2.8
Pretax Income	54.5	69.8	92.3	-87.7	23.4
+ Current Tax	11.1	12.1	14.5	2.4	4.9
+ Deferred Tax	-0.2	0.4	7.3	-7.3	-7.8
Tax Expense	10.9	12.5	21.9	-4.9	-2.9
Net Income	43.5	57.3	70.5	-82.8	26.3
+ Net Income — Continuing Ops	43.5	57.3	70.5	-82.8	26.3
+ Other Comprehensive Income	0.1	0.0	-0.1	3.2	5.1
Total Comprehensive Income	43.7	57.3	70.3	-79.6	31.4
Net Income to Common	43.5	57.2	69.6	-81.8	25.4
Minority Interest	0.0	0.1	0.9	-1.0	1.0
Per Share
Basic EPS	14.16	1.81	2.06	-2.14	0.67
Diluted EPS	14.16	1.54	2.06	-2.14	0.67
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	3.2	5.1
+ Items NOT to be Reclassified to P&L	-0.1	0.0	-0.7	-0.1	-0.1
+ Tax on Items NOT to be Reclassified	—	—	-0.1	-0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.0	—	—	—
+ Items to be Reclassified to P&L	0.2	0.0	0.5	3.2	5.1
Comprehensive Income — Owners of Parent	43.7	57.2	69.5	-78.6	30.4
Comprehensive Income — Non-controlling Interests	0.0	0.1	0.8	-1.0	1.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	14.16	1.81	2.06	-2.14	0.67
Diluted EPS — Continuing Operations	14.16	1.54	2.06	-2.14	0.67
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	163.7	203.8	266.1	230.1	228.3
Gross Margin %	54.19	51.09	54.50	48.16	48.48
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	54.5	69.8	92.3	30.5	20.6
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-118.2	2.8
Net Income Adj (tax-effected)	43.5	57.3	70.5	28.8	23.5
EPS Adj	14.16	1.81	2.06	0.74	0.60
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	30.7	32.8	38.2	38.2	38.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.